Navigation Links
Commercial Launch of Herceptin SC in EU Triggers Milestone Payment to Halozyme from Roche
Date:9/26/2013

s is known as "HER2 positivity" and affects approximately 15% to 20% of women with breast cancer.2 HER2-positive cancer is a particularly aggressive form of breast cancer.3

Halozyme-Roche Collaboration
In December 2006, Halozyme entered into an agreement with Roche to apply Halozyme's proprietary Enhanze™ technology to Roche's biological therapeutic compounds. To date, Roche has elected to develop and commercialize products using rHuPH20 with a total of five exclusive targets, and Roche retains the option to apply rHuPH20 to three additional targets through the payment of annual license maintenance fees. In February 2011, Roche began a Phase 3 registration trial of subcutaneous (SC) MabThera (rituximab), an anticancer biologic, in patients with non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) and submitted a line extension application to the European Medicines Agency for MabThera SC in December 2012. Subject to the successful achievement of clinical, regulatory, and sales events, Roche will pay Halozyme additional milestones as well as royalties on product sales for Herceptin SC, MabThera SC and other product candidates developed and commercialized under the agreement.

About Halozyme
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the absorption and dispersion of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need. The company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer, Baxter,
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
2. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
3. Acella Pharmaceuticals Announces a New Addition to the Commercial Team
4. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
5. New Executive Vice President Commercial Appointed
6. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
7. Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
8. Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial
9. Biodel Obtains Exclusive License to Aegis Therapeutics Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
10. Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies
11. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... KANSAS CITY, Kan. , Dec. 18, 2014 ... PETX ), a biopharmaceutical company focused on ... for companion animals, today announced positive results from ... company,s innovative drug for treating pain in dogs ... demonstrated improvements in pain assessment scores that were ...
(Date:12/17/2014)... -- Los beneficios y ganancias están por ... gasto en investigación y desarrollo   En ... septiembre de 2014) ZEISS aumentó sus ingresos en un ... anterior: 4.190 millones de euros) a pesar de los ... un 14 por ciento, a 360 millones de euros. ...
(Date:12/17/2014)... 17, 2014 With advancements in neurological ... market is seeing new growth, according to Kalorama ... account for the majority of market volume, newer ... images, which are creating opportunities for more sophisticated applications. ... growing at a rate of 4%, with world ...
Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5ZEISS confirma su posición en un entorno difícil 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3
... Stereotaxis, Inc. (Nasdaq: STXS ) announced today that ... September 30, 2010, on Monday, November 1, 2010 ... a conference call and webcast on Monday, November 1, ... Company,s third quarter results and corporate developments. The ...
... Oct. 25 Accuray Incorporated (Nasdaq: ARAY ), ... that it will report results for its first quarter of ... 2010 after the market closes. A conference call ... p.m. ET and will be hosted by Euan S. Thomson, ...
Cached Medicine Technology:Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call 2Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call 3Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2011 2
(Date:12/19/2014)... Sweetdressy.com , a leading wedding dress manufacturer for the ... prom dresses for ladies worldwide. The prom dresses from ... can buy these dresses at the website of Sweetdressy.com ... and delicate craftsmanship, and most of them are priced ... costs are available for all of their dresses. All ...
(Date:12/19/2014)... FL (PRWEB) December 19, 2014 ... Revitalizing Bedsheets are now available. Celliant, the world’s ... both sheets and pillowcases. , There are a ... proven additional circulation, increased oxygenation and balanced body ... faster healing and pain relief; enhanced athletic performance; ...
(Date:12/19/2014)... Silver Dollar City is picking ... for the first time ever, Silver Dollar City has a ... Records 2015, listing the park’s wood coaster Outlaw Run as ... awards announced this week, Silver Dollar City is named in ... US,” USA Today’s 10Best awards for “Best Public Lights Display,” ...
(Date:12/19/2014)... 2014 Eufaula, Oklahoma, located just 9 ... the state’s largest lake with more than 600 miles ... to a little more than 3,000 residents, hosted its ... the 6th of December. , Featuring Santa, Christmas lights ... Eufaula on Main Street. Narconon Arrowhead’s parade float ...
(Date:12/19/2014)... 20, 2014 An evening dress is perfect ... lady’s closet. Discount-Dress.com, a distinguished dresses retailer, has unveiled its ... dresses in this great shopping platform. Customers can ... staff's hard work, Discount-Dress.com has been accepted and praised by ... and easier shopping stage for clients. In order to expand ...
Breaking Medicine News(10 mins):Health News:Cheap Prom Dresses Online Now at Sweetdressy.com 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2
... to rid the brain of the amyloid buildup that plagues ... the method outlined in a paper published online August 12 ... Center show how the bodys natural way of ridding the ... disease. Then the team demonstrated an experimental method in mice ...
... 2007 UT Southwestern Medical Center researchers have discovered ... the human cardiovascular system, including lowering the elevated heart ... ,We have found that cocaines effects on the ... a drug called dexmedetomidine, which is currently approved by ...
... Food and Drug Administration (FDA) Nanotechnology Task Force is ... effort to tackle the new scientific and regulatory challenges ... clear and candid in acknowledging the pervasive potential of ... pharmaceuticals and devices to cosmetics and food supplements— and ...
... drug that stimulates the growth of infection-fighting white blood ... a chemotherapy-related complication characterized by fever and low white ... by researchers from the University of Rochester School of ... Center. , "Chemotherapy drugs target cancer cells, but ...
... scientists said Monday that they have further evidence to suggest ... would make a promising target for new drugs to ... first identified the enzyme, protein kinase G (PknG), as a ... time, they said that the protein is the secret weapon ...
... created from an egg matured in a laboratory, frozen, thawed ... a medical conference on Monday. ,The baby ... disease, and three other women in the 20-person trial group ... ,Doctors already collect and store eggs from women who face ...
Cached Medicine News:Health News:Draining away brain's toxic protein to stop Alzheimer's 2Health News:Draining away brain's toxic protein to stop Alzheimer's 3Health News:New treatment effective in counteracting cocaine-induced symptoms 2Health News:White Blood Cell Booster May Help Cancer Patients Avoid Deadly Complications 2Health News:Structure of TB Enzyme Points the Way to New Drugs: Study 2Health News:Infertility Breakthrough With First Birth from Lab-matured Egg 2Health News:Infertility Breakthrough With First Birth from Lab-matured Egg 3
Fluoro done? Get rid of your apron quickly and easily without breaking the sterile field. A shoulder drop-away can also be used with our Stretchy-back and cummmberbund aprons. Shoulder pads and hangi...
An economical solution to the need to provide wrap-around protection. The one-sided velcro closure allows greater flexibility in sizing. Front protection is 0.5mm Pb and the back is 0.25mm Pb equival...
A full protection apron with a plus. This wrap around features a unique 5 inch orthopedic adjustable belot that snaps on the apron to support the lower back, providing full body protection....
Weight is evenly distributed by fully adjustable velcro straps that cross in the back. Adjustable back velcro keeps apron snug....
Medicine Products: